RPL30P13

Across TCGA pan-cancer cohorts, RPL30P13 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPL30P13’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RPL30P13 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL30P13 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA are the cancer types where RPL30P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL30P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	III,IV	−0.075	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

RPL30P13–THCA

Open the THCA breakdown →